Effectiveness of taxane- or anthracyclin-based compared to taxane- and anthracycline-free first-line treatments of patients with metastatic breast cancer treated by German office-based medical oncologists. Data from the TMK Registry Group.

Marschner, N., Dörfel, S., Meyer, D., Petersen, V., Frank, M., Jänicke, M., Tesch, H., 2013.

The Breast 22 (suppl 3) (P41). doi:10.1016/S0960-9776(13)70055-9

Studie: TMK; Indikation: Mammakarzinom; Jahr: 2013; Veranstaltung: ABC2; Journal: The Breast

Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com